Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Vical and Pasteur Merieux Connaught initiate phase I malaria trial

July 14, 1997

Virus Research Institute's rotavirus vaccine enters phase II

July 11, 1997

Lepetit discovers IL-1RI inhibitors from microbial samples

July 10, 1997

FDA grants manufacturing approval for bulk ciclosporin

July 8, 1997

Preliminary results reported for Cortecs' Flustat

July 7, 1997

Natural immunosuppressive agent disclosed by Kyowa Hakko

July 3, 1997

Preclinical results reported for type I diabetes vaccine

June 30, 1997

ImmuLogic postpones Allervax Ragweed trial

June 30, 1997

North American Vaccine seeks FDA approval for DTaP-IPV vaccine trial

June 30, 1997

Ranitidine for infectious mononucleosis

June 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...